Prognostic Implications of Acute Renal Impairment among ST Elevation Myocardial Infarction Patients with Preserved

Yacov Shacham1, Amir Gal-Oz2, Jeremy Ben-Shoshan1

  • 1Departments of Cardiology, Tel Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Cardiorenal Medicine
|March 19, 2016
PubMed

Insights

Acute kidney injury (AKI) in ST-elevation myocardial infarction (STEMI) patients with preserved left ventricular function is linked to increased long-term mortality. This finding highlights the importance of monitoring kidney function post-primary PCI.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Research

Background:

  • Limited data exists on acute kidney injury (AKI) incidence and outcomes in ST-elevation myocardial infarction (STEMI) patients with preserved left ventricular (LV) function.
  • The primary percutaneous coronary intervention (PCI) era has changed STEMI management, necessitating updated understanding of AKI's role.

Purpose of the Study:

  • To investigate the incidence and prognostic implications of AKI in STEMI patients with preserved LV function undergoing primary PCI.
  • To assess the association between AKI and long-term all-cause mortality in this specific patient cohort.

Main Methods:

  • Retrospective study of 842 STEMI patients with ejection fraction ≥50% who underwent primary PCI (Jan 2008 - Jan 2015).
  • AKI defined as serum creatinine increase ≥0.3 mg/dl within 48 hours of admission.
  • All-cause mortality assessed up to 5 years post-admission.

Main Results:

  • AKI developed in 6.2% of patients (52/842).
  • AKI patients were older, had poorer baseline renal function, and higher rates of heart failure.
  • AKI was associated with significantly higher 5-year all-cause mortality (13.4% vs. 2.4%, p < 0.001).
  • Adjusted hazard ratio for all-cause mortality in AKI patients was 2.64 (p = 0.01).

Conclusions:

  • Acute kidney injury is a significant complication in STEMI patients with preserved LV function undergoing primary PCI.
  • AKI is independently associated with increased long-term all-cause mortality in this population.
  • Findings underscore the need for vigilance regarding kidney function in STEMI patients with preserved LV function post-PCI.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
459
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
687
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.1K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
312